Cross Country Healthcare Inc (CCRN)

$13.47

-0.41

(-2.95%)

Market is closed - opens 7 PM, 12 Sep 2024

Performance

  • $13.34
    $13.89
    $13.47
    downward going graph

    0.97%

    Downside

    Day's Volatility :3.96%

    Upside

    3.02%

    downward going graph
  • $12.87
    $25.76
    $13.47
    downward going graph

    4.45%

    Downside

    52 Weeks Volatility :50.04%

    Upside

    47.71%

    downward going graph

Returns

PeriodCross Country Healthcare Inc
3 Months
-6.98%
6 Months
-26.75%
1 Year
-42.01%
3 Years
-35.64%

Highlights

Market Capitalization
469.3M
Book Value
$13.15
Earnings Per Share (EPS)
0.25
PE Ratio
55.52
PEG Ratio
1.94
Wall Street Target Price
18.6
Profit Margin
0.54%
Operating Margin TTM
-3.84%
Return On Assets TTM
2.75%
Return On Equity TTM
1.87%
Revenue TTM
1.6B
Revenue Per Share TTM
45.79
Quarterly Revenue Growth YOY
-37.2%
Gross Profit TTM
627.7M
EBITDA
48.1M
Diluted Eps TTM
0.25
Quarterly Earnings Growth YOY
-0.9
EPS Estimate Current Year
0.52
EPS Estimate Next Year
0.7
EPS Estimate Current Quarter
0.13
EPS Estimate Next Quarter
0.16

Analyst Recommendation

Buy
    53%Buy
    40%Hold
    6%Sell
Based on 15 Wall street analysts offering stock ratings for Cross Country Healthcare Inc(by analysts ranked 0 to 5 stars)
Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
6
6
6
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 38.08%

Current $13.47
Target $18.60

Company Financials

FY18Y/Y Change
Revenue
816.5M
↓ 5.61%
Net Income
-17.0M
↓ 145.19%
Net Profit Margin
-2.08%
↓ 6.42%
FY19Y/Y Change
Revenue
822.2M
↑ 0.7%
Net Income
-55.9M
↑ 230.03%
Net Profit Margin
-6.8%
↓ 4.72%
FY20Y/Y Change
Revenue
836.4M
↑ 1.73%
Net Income
-12.1M
↓ 78.3%
Net Profit Margin
-1.45%
↑ 5.35%
FY21Y/Y Change
Revenue
1.7B
↑ 100.46%
Net Income
132.0M
↓ 1187.15%
Net Profit Margin
7.87%
↑ 9.32%
FY22Y/Y Change
Revenue
2.8B
↑ 67.39%
Net Income
188.5M
↑ 42.77%
Net Profit Margin
6.71%
↓ 1.16%
FY23Y/Y Change
Revenue
2.0B
↓ 28.04%
Net Income
72.6M
↓ 61.46%
Net Profit Margin
3.6%
↓ 3.11%
Q1 FY23Q/Q Change
Revenue
622.7M
↓ 0.88%
Net Income
29.4M
↓ 24.12%
Net Profit Margin
4.73%
↓ 1.44%
Q2 FY23Q/Q Change
Revenue
540.7M
↓ 13.17%
Net Income
21.3M
↓ 27.49%
Net Profit Margin
3.95%
↓ 0.78%
Q3 FY23Q/Q Change
Revenue
442.3M
↓ 18.2%
Net Income
12.8M
↓ 39.98%
Net Profit Margin
2.9%
↓ 1.05%
Q4 FY23Q/Q Change
Revenue
414.0M
↓ 6.39%
Net Income
9.0M
↓ 29.46%
Net Profit Margin
2.18%
↓ 0.72%
Q1 FY24Q/Q Change
Revenue
379.2M
↓ 8.42%
Net Income
2.7M
↓ 70.21%
Net Profit Margin
0.71%
↓ 1.47%
Q2 FY24Q/Q Change
Revenue
339.8M
↓ 10.39%
Net Income
-16.1M
↓ 696.21%
Net Profit Margin
-4.72%
↓ 5.43%
FY18Y/Y Change
Total Assets
427.0M
↓ 8.7%
Total Liabilities
208.8M
↓ 9.2%
FY19Y/Y Change
Total Assets
382.4M
↓ 10.45%
Total Liabilities
218.9M
↑ 4.82%
FY20Y/Y Change
Total Assets
357.0M
↓ 6.64%
Total Liabilities
202.1M
↓ 7.68%
FY21Y/Y Change
Total Assets
732.8M
↑ 105.28%
Total Liabilities
435.3M
↑ 115.42%
FY22Y/Y Change
Total Assets
947.8M
↑ 29.34%
Total Liabilities
490.6M
↑ 12.71%
FY23Y/Y Change
Total Assets
679.3M
↓ 28.33%
Total Liabilities
205.9M
↓ 58.03%
Q1 FY23Q/Q Change
Total Assets
920.5M
↓ 2.88%
Total Liabilities
468.6M
↓ 4.49%
Q2 FY23Q/Q Change
Total Assets
771.1M
↓ 16.23%
Total Liabilities
300.8M
↓ 35.81%
Q3 FY23Q/Q Change
Total Assets
707.7M
↓ 8.22%
Total Liabilities
238.1M
↓ 20.85%
Q4 FY23Q/Q Change
Total Assets
679.3M
↓ 4.02%
Total Liabilities
205.9M
↓ 13.51%
Q1 FY24Q/Q Change
Total Assets
648.4M
↓ 4.55%
Total Liabilities
180.2M
↓ 12.47%
Q2 FY24Q/Q Change
Total Assets
602.9M
↓ 7.03%
Total Liabilities
163.8M
↓ 9.11%
FY18Y/Y Change
Operating Cash Flow
21.0M
↓ 53.86%
Investing Cash Flow
-6.7M
↓ 92.69%
Financing Cash Flow
-23.8M
↓ 146.83%
FY19Y/Y Change
Operating Cash Flow
5.5M
↓ 73.61%
Investing Cash Flow
-2.9M
↓ 55.97%
Financing Cash Flow
-17.6M
↓ 25.95%
FY20Y/Y Change
Operating Cash Flow
27.2M
↑ 390.87%
Investing Cash Flow
-4.6M
↑ 56.97%
Financing Cash Flow
-22.0M
↑ 25.06%
FY21Y/Y Change
Operating Cash Flow
-85.6M
↓ 414.73%
Investing Cash Flow
-34.0M
↑ 637.72%
Financing Cash Flow
119.1M
↓ 641.09%
FY22Y/Y Change
Operating Cash Flow
134.1M
↓ 256.57%
Investing Cash Flow
-43.9M
↑ 28.87%
Financing Cash Flow
-87.6M
↓ 173.55%
Q1 FY23Q/Q Change
Operating Cash Flow
46.9M
↑ 984.84%
Investing Cash Flow
-3.5M
↓ 90.58%
Financing Cash Flow
-46.7M
↓ 868.41%
Q2 FY23Q/Q Change
Operating Cash Flow
119.2M
↑ 154.45%
Investing Cash Flow
-4.0M
↑ 14.3%
Financing Cash Flow
-114.9M
↑ 146.08%

Technicals Summary

Sell

Neutral

Buy

Cross Country Healthcare Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

Institutional Holdings

  • BlackRock Inc

    17.52%
  • Pacer Advisors, INC.

    13.46%
  • Vanguard Group Inc

    7.39%
  • Dimensional Fund Advisors, Inc.

    6.98%
  • Wasatch Advisors LP

    5.19%
  • Systematic Financial Management LP

    4.53%

Company Information

cross country healthcare, headquartered in boca raton, florida, is a national leader in providing leading-edge healthcare workforce solutions. our solutions are geared towards assisting our clients to solve labor cost issues while maintaining high quality outcomes. with more than 30 years of experience, we are dedicated to placing highly qualified nurses and physicians as well as allied health, advanced practice, and case management professionals. we also provide both retained and contingent placement services for physicians, as well as retained search services for healthcare executives. we have more than 6,500 active contracts with a broad range of clients in both clinical and nonclinical settings, including acute care hospitals, physician practice groups, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and home care. through our national staffing teams and network of more than 70 branch office locations,

Organization
Cross Country Healthcare Inc
Employees
13131
CEO
Mr. Kevin Cronin Clark
Industry
Commercial Services

FAQs